Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Press release

Mentice AB: BioStock: Mentice comments on strong Q4 financial performance

Mentice

Mentice ended the year on a high note with a strong Q4, driven by large orders from top medical device companies. However, full-year order intake declined, and some challenges remain to achieve strong, sustained growth. Newly appointed CEO Frans Venker emphasized the need to enhance commercial execution in the US market and leverage new products to drive accelerated growth.

Read the full article at biostock.se:

https://www.biostock.se/en/2025/02/mentice-comments-on-strong-q4-financial-performance/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.